BLUE PEARL TEXSPIN | BRAWN BIOTECH | BLUE PEARL TEXSPIN/ BRAWN BIOTECH |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 566.1 | -5.5 | - | View Chart |
P/BV | x | - | 1.1 | - | View Chart |
Dividend Yield | % | 0.0 | 0.0 | - |
BLUE PEARL TEXSPIN BRAWN BIOTECH |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
BLUE PEARL TEXSPIN Mar-23 |
BRAWN BIOTECH Mar-23 |
BLUE PEARL TEXSPIN/ BRAWN BIOTECH |
5-Yr Chart Click to enlarge
|
||
High | Rs | 36 | 23 | 155.4% | |
Low | Rs | 25 | 14 | 187.1% | |
Sales per share (Unadj.) | Rs | 8.6 | 74.1 | 11.6% | |
Earnings per share (Unadj.) | Rs | -0.3 | -2.9 | 9.3% | |
Cash flow per share (Unadj.) | Rs | -0.3 | -2.5 | 10.6% | |
Dividends per share (Unadj.) | Rs | 0 | 0 | - | |
Avg Dividend yield | % | 0 | 0 | - | |
Book value per share (Unadj.) | Rs | -4.5 | 21.0 | -21.2% | |
Shares outstanding (eoy) | m | 0.26 | 3.00 | 8.7% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 3.5 | 0.2 | 1,419.3% | |
Avg P/E ratio | x | -107.6 | -6.3 | 1,708.9% | |
P/CF ratio (eoy) | x | -107.6 | -7.2 | 1,493.9% | |
Price / Book Value ratio | x | -6.7 | 0.9 | -774.4% | |
Dividend payout | % | 0 | 0 | - | |
Avg Mkt Cap | Rs m | 8 | 55 | 14.3% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 0 | 14 | 1.4% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 2 | 222 | 1.0% | |
Other income | Rs m | 0 | 0 | 0.0% | |
Total revenues | Rs m | 2 | 222 | 1.0% | |
Gross profit | Rs m | 0 | -3 | 2.3% | |
Depreciation | Rs m | 0 | 1 | 0.0% | |
Interest | Rs m | 0 | 0 | 0.0% | |
Profit before tax | Rs m | 0 | -4 | 1.7% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 0 | 5 | 0.0% | |
Profit after tax | Rs m | 0 | -9 | 0.8% | |
Gross profit margin | % | -3.2 | -1.4 | 236.2% | |
Effective tax rate | % | 0 | -110.8 | 0.0% | |
Net profit margin | % | -3.2 | -3.9 | 82.4% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 2 | 134 | 1.3% | |
Current liabilities | Rs m | 3 | 80 | 3.9% | |
Net working cap to sales | % | -62.4 | 24.1 | -259.3% | |
Current ratio | x | 0.6 | 1.7 | 33.2% | |
Inventory Days | Days | 35 | 10 | 351.0% | |
Debtors Days | Days | 1,348,184 | 87,270 | 1,544.8% | |
Net fixed assets | Rs m | 0 | 10 | 2.4% | |
Share capital | Rs m | 3 | 30 | 8.5% | |
"Free" reserves | Rs m | -4 | 33 | -11.2% | |
Net worth | Rs m | -1 | 63 | -1.8% | |
Long term debt | Rs m | 0 | 0 | - | |
Total assets | Rs m | 2 | 144 | 1.3% | |
Interest coverage | x | 0 | -44.7 | - | |
Debt to equity ratio | x | 0 | 0 | - | |
Sales to assets ratio | x | 1.1 | 1.5 | 74.3% | |
Return on assets | % | -3.7 | -6.0 | 61.8% | |
Return on equity | % | 6.2 | -13.8 | -45.0% | |
Return on capital | % | 6.2 | -6.4 | -96.9% | |
Exports to sales | % | 0 | 0 | - | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | NA | NA | - | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 0 | 0 | - | |
Fx outflow | Rs m | 0 | 0 | - | |
Net fx | Rs m | 0 | 0 | - |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 0 | 3 | -14.5% | |
From Investments | Rs m | NA | -1 | -0.0% | |
From Financial Activity | Rs m | 1 | NA | -625.0% | |
Net Cashflow | Rs m | 0 | 2 | 1.9% |
Indian Promoters | % | 0.1 | 53.6 | 0.2% | |
Foreign collaborators | % | 19.5 | 0.0 | - | |
Indian inst/Mut Fund | % | 0.0 | 0.4 | 5.7% | |
FIIs | % | 0.0 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 80.3 | 46.4 | 173.3% | |
Shareholders | 8,401 | 4,160 | 201.9% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare BLUE PEARL TEXSPIN With: ADANI ENTERPRISES MMTC REDINGTON SIRCA PAINTS INDIA NOVARTIS
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | E-WHA FOAM (I) | BRAWN PHARMA |
---|---|---|
1-Day | 0.00% | 4.99% |
1-Month | 4.98% | 24.13% |
1-Year | 25.40% | 28.01% |
3-Year CAGR | 59.11% | -6.20% |
5-Year CAGR | 27.07% | -10.58% |
* Compound Annual Growth Rate
Here are more details on the E-WHA FOAM (I) share price and the BRAWN PHARMA share price.
Moving on to shareholding structures...
The promoters of E-WHA FOAM (I) hold a 19.7% stake in the company. In case of BRAWN PHARMA the stake stands at 53.6%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of E-WHA FOAM (I) and the shareholding pattern of BRAWN PHARMA.
Finally, a word on dividends...
In the most recent financial year, E-WHA FOAM (I) paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of -0.0%.
BRAWN PHARMA paid Rs 0.0, and its dividend payout ratio stood at -0.0%.
You may visit here to review the dividend history of E-WHA FOAM (I), and the dividend history of BRAWN PHARMA.
After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.